Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease
This study validated the efficacy of the acFibroMASH index in predicting at-risk MASH in a population of MASLD patients, demonstrating comparable performance to that of the FAST. The acFibroMASH index may provide a valuable clinical basis for screening and identifying at-risk MASH in primary care settings.
Authors
- Wenjian Li (ORCID: https://orcid.org/0000-0002-7650-8842)
- Longgen Liu (ORCID: https://orcid.org/0000-0001-8652-2499)
- Yan Han (ORCID: https://orcid.org/0000-0002-2041-3115)
- Yunfei Wu (ORCID: https://orcid.org/0000-0002-3950-4367)
- Fan Zhang (ORCID: https://orcid.org/0000-0003-0120-4892)
- Liming Zheng (ORCID: https://orcid.org/0000-0002-2133-2325)
Institutions
- Changzhou No.2 People's Hospital (CN)
- Changzhou Third People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1186/s12876-025-03781-7
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Changzhou Science and Technology Bureau